compound oral tirzepatide Compounded Tirzepatide: Patient Information and FAQs Compounded Tirzepatide

Tirzepatide is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist

( Wegovy , a semaglutide that is approved for weight loss, has already established such a registry.) In the scientific literature, theres at least one such retrospective case of a woman who didnt know she was pregnant taking semaglutide up until about the fourth week of her pregnancy

Essential testing before and during treatment: Medical experts recommend testing to identify correctible deficiencies

If you're also taking insulin or sulfonylureas, dose adjustments of these medications may be needed to reduce the risk of hypoglycaemia